185 - Netflix and Chill: Comprehensive Sexual Health Services in the HIV Clinic

Friday, October 13, 2023

3:15 PM – 4:30 PM US ET

Location: 258 ABC

All relevant financial disclosures have been mitigated.

Moderator(s)

Colleen Kelley, MD, MPH (she/her/hers)

Associate Professor of Medicine
Emory University
Decatur, GA, United States
Joseph Cherabie, MD, MSc (they/them/theirs)

Assistant Professor
Washington University St. Louis
Saint Louis, MO, United States
Aimalohi Ahonkhai, MD, MPH

Assistant Professor of Medicine
Division of Infectious Diseases
Vanderbilt University Medical Center
Nashville, TN, United States

Faculty(s)

Mary Foote, MD MPH

Medical Director
Office of Emergency Preparedness and Response
New York City Department of Health and Mental Hygiene
Brooklyn, NY, United States

Slides
Annie Luetkemeyer, MD (she/her/hers)

Professor of Medicine
University of California San Francisco
San Francisco, CA, United States

Slides
Jodie Dionne, MD, MSPH (she/her/hers)

Associate Professor of Medicine
Medicine/Infectious Diseases
University of Alabama at Birmingham
Birmingham, AL, United States

Slides

Disclosure(s):

Colleen F. Kelley, MD, MPH: Gilead Sciences: Grant/Research Support (Ongoing); Humanigen: Grant/Research Support (Ongoing); Moderna, Inc.: Grant/Research Support (Ongoing); Novavax, Inc: Grant/Research Support (Ongoing); Viiv Healthcare: Grant/Research Support (Ongoing)

Joseph Cherabie, MD, MSc: No financial relationships to disclose

Aimalohi Ahonkhai, MD, MPH: DKB MED LLC: Honoraria (Terminated, December 31, 2021); Gilead: Non-Branded Speaker Training (Ongoing); Integritas: Honoraria (Ongoing); Vindico CME: Speaker (Terminated, December 31, 2022)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

explain factors affecting mpox risk and outcomes among people with HIV;
analyze the use of DoxyPep for preventing sexually transmitted infections;
describe the current landscape of vaccination for sexually transmitted infections

Presentations:

3:15 PM – 3:40 PM US ET

The Mpox and HIV Experience
Speaker: Mary K. Foote, MD MPH – New York City Department of Health and Mental Hygiene
3:40 PM – 4:05 PM US ET

Doxy Post-Exposure Prophylaxis in the Real World: Considerations for Implementation
Speaker: Annie Luetkemeyer, MD (she/her/hers) – University of California San Francisco
4:05 PM – 4:30 PM US ET

Vaccination for Sexually Transmitted Infections
Speaker: Jodie A. Dionne, MD, MSPH (she/her/hers) – University of Alabama at Birmingham